Ignite Creation Date:
2025-12-24 @ 12:47 PM
Ignite Modification Date:
2026-04-17 @ 2:56 PM
Study NCT ID:
NCT06081361
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-01
First Post:
2023-09-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort
Sponsor:
Organization: